In the Methods section of this Letter, the description of immunohistochemical (IHC) analysis did not clearly describe the scoring system we used. To avoid confusion, the assignment of proportion scores should have been described as follows: “0 if 0% of the tumour cells showed positive staining, 0.1–1.0 if 0.1% to 1% of cells were stained, 1.1–2.0 if 1.1% to 10% stained, 2.1–3.0 if 11% to 30% stained, 3.1–4.0 if 31% to 70% stained, and 4.1–5.0 if 71% to 100% stained. (Each percentage range of the stained tumour section is further divided into ten smaller percentage ranges and represented by corresponding non-integral scores, such as 3.1 representing 31%–34%). We rated the intensity of staining on a scale of 0 to 3: 0, negative; 1, weak; 2, moderate; and 3, strong. We then combined the proportion and intensity scores to obtain a total score (range, 0–8), as described previously.”
In addition, in Supplementary Fig. 20, the x and y axes labels of each of the three graphs were inadvertently reversed. A revised figure is included as Supplementary Information to this Corrigendum. The data in all panels remain unchanged, and these errors do not affect the results or conclusions of the Letter.
We apologize any confusion this may have caused. The original Letter has not been corrected.
The online version of the original article can be found at 10.1038/nature10598
Rights and permissions
About this article
Cite this article
Yang, W., Xia, Y., Ji, H. et al. Correction: Corrigendum: Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature 550, 142 (2017). https://doi.org/10.1038/nature24008
This article is cited by
ERK/PKM2 Is Mediated in the Warburg Effect and Cell Proliferation in Arsenic-Induced Human L-02 Hepatocytes
Biological Trace Element Research (2023)
Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin
Cell Communication and Signaling (2022)
Identification of novel candidate genes and predicted miRNAs in atopic dermatitis patients by bioinformatic methods
Scientific Reports (2022)
Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cells
Stem Cell Reviews and Reports (2022)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.